PERIORBITAL FAT ATROPHY

PERIORBITAL FAT ATROPHY was reported 43 times

PERIORBITAL FAT ATROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Semifluorinated Alkane [EPC] 1 0.0004
1 Cytolytic Agent [EPC] 1 0.0004
2 Prostaglandin Analog [EPC] 29 0.0003
3 Antiparasitic [EPC] 1 0.0002
4 Pediculicide [EPC] 1 0.0002
5 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 1 0.0002
6 Progesterone [EPC] 1 0.0000
7 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
8 5-alpha Reductase Inhibitor [EPC] 1 0.0000
9 Calcium [EPC] 1 0.0000
10 Aldosterone Antagonist [EPC] 1 0.0000
11 Vitamin D [EPC] 1 0.0000
12 beta-Adrenergic Blocker [EPC] 1 0.0000
13 Vitamin B12 [EPC] 1 0.0000
14 Vitamin C [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
16 Platelet Aggregation Inhibitor [EPC] 1 0.0000
17 Corticosteroid [EPC] 1 0.0000
18 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000